The nervous system - made up of the brain, spinal cord and nerves - controls how the body functions. When something goes wrong with this system, the impact can be severe, affecting one's ability to move, speak, swallow and learn. While neurologic diseases - conditions that affect the brain - are more common among the elderly, their prevalence is increasing as life expectancies increase.
Addressing neurological disease is
therefore a social as well as a medical priority. To this end,
NEUROBIOTECH, a NEUROMED-led project, was recently set up in order to
establish an international research and innovation community on
neuroscience. NEUROBIOTECH aims to pull together experts from across the
globe in order to share knowledge and stimulate research activities.
The ultimate goal of this community-based approach is to ensure that
as many people as possible are able to benefit from advances in
neurobiology, from medical professionals to local citizens. The project
will enable researchers to work together, and promises to offer
solutions for improving healthcare.
Scientific knowledge of the nervous system has increased
significantly, principally due to advances in molecular biology and
computational neuroscience. This has allowed neuroscientists to study
the nervous system at a much deeper level. However, greater
collaboration is still needed in order to translate this scientific
understanding into medical benefits, and this is where NEUROBIOTECH
comes in.
The project began by launching an invitation to experts interested
in sharing methods, knowledge, people and ideas. The new Centre will
focus on research fields that promise important breakthroughs, such as
genomics - the study and sequencing of DNA - and stem cells. Stem cells
are able to self-renew; i.e. to divide and produce identical copies over
and over again. This makes them different to specialised cells - like
blood cells - which cannot replicate themselves and can therefore be
seriously damaged by disease or injury.
Experts in these and other specialised fields will be able to use
NEUROBIOTECH as a forum to collaborate and share research and ideas, and
as a place where they can translate ideas into products or improvements
in clinical practice. Indeed, one of the major attractions of the
project will be access to state-of-the-art facilities in Pozzilli, Italy
and Brussels, including a radioisotope laboratory, a cell factory and
an advanced imaging centre. The findings of NEUROBIOTECH will be made
available in order to help guide future research policy.
The project is being led by NEUROMED, an Italy-based research centre
specialising in neuroscience. The centre works in cooperation with the
Molise Regional Government, the Italian National Research Council, the
Universities of Rome Sapienza, Tor Vergata and Molise. Several foreign
research centres and companies have also agreed to participate in the
NEUROBIOTECH cluster.
The Pozzilli facility is situated in an area that has been hard hit
by the economic crisis. Investment in local-based research has the
potential to create new high value jobs, and could help to kick-start
the regional economy. As a partner of the project, the Molise Regional
Government has set aside financial resources for companies and research
centres wishing to invest in the region.
Source: NEUROMED
Reference documents: Based on a CORDIS Wire press release from NEUROMED